CoChat

Alginate-based tissue-specific bioinks for multi-material 3D-bioprinting of pancreatic islets and blood vessels: A step towards vascularized pancreas grafts

Open access
Idaszek, Joanna, Volpi, Marina, Paradiso, Alessia, Nguyen Quoc, Martyna, Górecka, Żaneta, Klak, Marta, Tymicki, Grzegorz, Berman, Andrzej, Wierzbicki, Mateusz, Jaworski, Sławomir, Costantini, Marco, Kępczyńska, Agnieszka, Chwalibóg, Ewa Sawosz, Wszoła, Michał, Święszkowski, Wojciech · 2021 · Bioprinting
Cited by 53

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Although allogeneic islet transplantation has been proposed as a therapy for type 1 diabetes, its success rate remains low. Disruption of both extracellular matrix (ECM) and dense vascular network during islets isolation are referred to as some of the main causes of their poor engraftment. Therefore, the recapitulation of the native pancreatic microenvironment and its prompt revascularization should be beneficial for long-term islet survival. In this study, we developed novel bioinks suitable for the microfluidic-assisted multi-material biofabrication of 3D porous pancreatic and vascular structures. The tissue-specific bioactivity was introduced by blending alginate either with pancreatic decellularized extracellular matrix powder (A_ECM) or fibrinogen (A_FBR). The formulated bioinks, although they exhibited different rheological properties, were 3D-printed with high shape fidelity using a multichannel microfluidic platform coupled with a co-axial needle system. The A_FBR scaffolds were subjected to secondary crosslinking using thrombin, which significantly decreased their swelling and increased mechanical properties. To investigate the bioactivity, the A_ECM and A_FBR bioinks were laden with, respectively, porcine pancreatic islets and a mixture of vessel-forming cells (HUVEC and HMSC) and 3D-bioprinted with high viability. Insulin secretion upon glucose stimulation and developed vessel-like structures composed of CD31-positive cells validated the biomimetic potential of the two formulated bioinks. Moreover, we demonstrated the feasibility of the secondary crosslinking to modulate cell behaviour and angiogenic potential both in vitro and in vivo using a chick chorioallantoic membrane model. Finally, the successful 3D-printing of heterogeneous 3D scaffolds with three different configurations demonstrated that our approach could be considered as a potential step towards the biofabrication of a vascularized pancreas construct.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bprint.2021.e00163

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 53

Metadata

Authors
Idaszek, J., Volpi, M., Paradiso, A., Nguyen Quoc, M., Górecka, Ż., Klak, M., Tymicki, G., Berman, A., Wierzbicki, M., Jaworski, S., Costantini, M., Kępczyńska, A., Chwalibóg, E. S., Wszoła, M., & Święszkowski, W.
Venue
Bioprinting
Publisher
Elsevier BV
Published
2021-12
Volume
24
Pages
e00163
ISSN
2405-8866 (ISSN-L)
OpenAlex
W3191481564
Cited by
53
References
11
FWCI
2.45
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alginate-based tissue-specific bioinks for multi-material 3D-bioprinting of pancreatic islets and blood vessels: A step towards vascularized pancreas grafts. https://app.cochat.ai/papers/10.1016/j.bprint.2021.e00163
The paper
Idaszek, J., Volpi, M., Paradiso, A., Nguyen Quoc, M., Górecka, Ż., Klak, M., Tymicki, G., Berman, A., Wierzbicki, M., Jaworski, S., Costantini, M., Kępczyńska, A., Chwalibóg, E. S., Wszoła, M., & Święszkowski, W. (2021). Alginate-based tissue-specific bioinks for multi-material 3D-bioprinting of pancreatic islets and blood vessels: A step towards vascularized pancreas grafts. Bioprinting. https://doi.org/10.1016/j.bprint.2021.e00163

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.